Results 71 to 80 of about 8,953 (196)
PD‐L1‐Inhibitor‐Associated Hidradenitis Suppurativa
Journal of Cutaneous Pathology, EarlyView.
Annie Jin +2 more
wiley +1 more source
Systemic Disease Associations of Oral Lichenoid Disease: A Retrospective Case–Control Study
Oral Diseases, EarlyView.ABSTRACT Objective To analyze the association between oral lichen planus (OLP), oral lichenoid lesions (OLL), and other comorbidities. Material and Methods A case–control study of 205 OLP, 96 OLL patients, and 301 age‐ and sex‐matched controls from Kuopio University Hospital was performed.
Mari Vehviläinen +3 more
wiley +1 more source
Coexistence of psoriasis with bullous pemphigoid
Indian Dermatology Online Journal, 2012 Psoriasis vulgaris and bullous pemphigoid (BP) represent two clinically well-characterized, chronic, inflammatory skin conditions. The concomitant occurrence of these two entities in a patient is rare.
Raghavendra Rao +4 more
doaj +1 more source
Dupilumab as a treatment for bullous pemphigoid in a liver transplant recipient: A case report
SAGE Open Medical Case ReportsBullous pemphigoid is a common subepidermal autoimmune bullous disease that affects the skin and mucous membranes. It is more prevalent in the elderly, often resulting in significant morbidity and mortality.
Sarah S. Rashid +2 more
doaj +1 more source
Study of Clinical Characteristics of Desquamative Gingivitis in 60 Patients in the North of Spain
International Journal of Dental Hygiene, Volume 24, Issue 3, Page 404-410, August 2026.ABSTRACT Objectives The aim of this study is to know the clinical characteristics of desquamative gingivitis (DG) in a Spanish population in order to make an early diagnosis of this sign and, therefore, the underlying systemic disease. Methods A cross‐sectional study was conducted.
Valeria Sanmartín‐Barragáns +7 more
wiley +1 more source
Dupilumab‐Induced Psoriasis in a Patient with Bullous Pemphigoid
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Nina Matthes +6 more
wiley +1 more source
Autoimmune Disease Risk With GLP‐1RA, DPP‐4i, and SGLT2i Treatment in Patients With Diabetes
ACR Open Rheumatology, Volume 8, Issue 7, July 2026.Objective Dipeptidyl peptidase‐4 inhibitors (DPP‐4i), glucagon‐like peptide‐1 receptor agonists (GLP‐1RA), and sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) are widely used for type 2 diabetes, yet their comparative immunologic safety is uncertain.
Arjun Mahajan +5 more
wiley +1 more source
Frontiers in Immunology, 2018 Background: Bullous pemphigoid is a subepidermal blistering skin disease, associated with autoantibodies to hemidesmosomal proteins, complement activation at the dermal-epidermal junction, and dermal granulocyte infiltration.
Roxana M. Chiorean +9 more
doaj +1 more source
Unusual Bullous Manifestation of Scabies in Childhood Diagnosed by Dermoscopy: A Case Report
Clinical Case Reports, Volume 14, Issue 7, July 2026.ABSTRACT Scabies is a common ectoparasitic infestation, but atypical variants such as bullous scabies are rare and often misdiagnosed. We report a 12‐year‐old boy who presented with pruritic lesions comprising predominantly vesicles and bullae over the hands, along with a few scattered excoriated papules on the trunk and thighs.
Anupa Khadka, Vikash Paudel
wiley +1 more source